This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on december 8, 2016.(b)(4).The sample was returned for evaluation.The sample was visually inspected, during which no anomalies were noted.During the decontamination process, bleach solution and water were circulated through the device.It was found that the fluid leaked through the gas ports during this circulation.No pressure was applied to the device during this circulation.It was found that there was a leak in the pipes of the heat exchanger.A retention sample from the same product code/lot number combination was obtained for evaluation.Visual inspection found no anomalies on the retention sample.The blood side of the unit was then filled with water and pressurized to approximately 650 mmhg.No leaks were noted from anywhere on the device, specifically through the gas ports.A review of the device history record revealed no manufacturing anomalies.All heat exchangers are leak tested in process; therefore, it is likely that damage occurred to the device at some point after manufacture that caused a pipe(s) in the heat exchanger to leak.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|